Yu J, Kiss Z, Ma W, Liang R, Li T
Cancers (Basel). 2025; 17(1.
PMID: 39796653
PMC: 11718887.
DOI: 10.3390/cancers17010022.
Rominger M, Gupta S, Moorthi S, McSharry M, Kamlapurkar S, OBrien S
bioRxiv. 2024; .
PMID: 39605726
PMC: 11601272.
DOI: 10.1101/2024.11.11.623044.
Yi Y, Dai L, Lan Y, Tan C, Vazquez-Blomquist D, Zeng G
Sci Rep. 2024; 14(1):26038.
PMID: 39472715
PMC: 11522547.
DOI: 10.1038/s41598-024-75990-1.
Galassi R, Sargentoni N, Renzi S, Luciani L, Bartolacci C, Pattabhi P
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338298
PMC: 11435220.
DOI: 10.3390/ph17091133.
Yeh S, Paithankar S, Chen R, Xing J, Sun M, Liu K
Genomics Proteomics Bioinformatics. 2024; 22(2).
PMID: 39240541
PMC: 11378636.
DOI: 10.1093/gpbjnl/qzad008.
Applications of lung cancer organoids in precision medicine: from bench to bedside.
Li H, Chen Z, Chen N, Fan Y, Xu Y, Xu X
Cell Commun Signal. 2023; 21(1):350.
PMID: 38057851
PMC: 10698950.
DOI: 10.1186/s12964-023-01332-9.
Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities.
Leon C, Manley Jr E, Neely A, Castillo J, Ramos Correa M, Velarde D
Front Oncol. 2023; 13():1187585.
PMID: 38023251
PMC: 10651223.
DOI: 10.3389/fonc.2023.1187585.
Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC).
Recuero E, Lazaro S, Lorz C, Enguita A, Garcia-Escudero R, Santos M
Int J Mol Sci. 2023; 24(20).
PMID: 37894963
PMC: 10607103.
DOI: 10.3390/ijms242015284.
Cell Culture Model Evolution and Its Impact on Improving Therapy Efficiency in Lung Cancer.
Roman V, Mihaila M, Radu N, Marineata S, Diaconu C, Bostan M
Cancers (Basel). 2023; 15(20).
PMID: 37894363
PMC: 10605536.
DOI: 10.3390/cancers15204996.
Characterization of 3D-Bioprinted In Vitro Lung Cancer Models Using RNA-Sequencing Techniques.
Zou S, Ye J, Wei Y, Xu J
Bioengineering (Basel). 2023; 10(6).
PMID: 37370598
PMC: 10295518.
DOI: 10.3390/bioengineering10060667.
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
Wang H, Zhang C, Peng K, Chen Z, Su J, Li Y
Cell Rep Med. 2023; 4(2):100911.
PMID: 36657446
PMC: 9975107.
DOI: 10.1016/j.xcrm.2022.100911.
PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review.
Yin N, Liu X, Ye X, Song W, Lu J, Chen X
Front Oncol. 2022; 12:961266.
PMID: 36119464
PMC: 9478917.
DOI: 10.3389/fonc.2022.961266.
Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?.
Bosakova V, De Zuani M, Sladkova L, Garlikova Z, Jose S, Zelante T
Front Cell Dev Biol. 2022; 10:899368.
PMID: 35912110
PMC: 9326165.
DOI: 10.3389/fcell.2022.899368.
Patient-Derived Lung Tumoroids-An Emerging Technology in Drug Development and Precision Medicine.
Le H, Seitlinger J, Lindner V, Olland A, Falcoz P, Benkirane-Jessel N
Biomedicines. 2022; 10(7).
PMID: 35884982
PMC: 9312903.
DOI: 10.3390/biomedicines10071677.
Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.
Han J, Kim Y, Kim H, Lee J, Oh M, Kim S
Cancer Commun (Lond). 2022; 42(8):716-749.
PMID: 35838183
PMC: 9395322.
DOI: 10.1002/cac2.12332.
Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.
Park J, Chandra R, Cai L, Ganguly D, Li H, Toombs J
J Thorac Oncol. 2022; 17(10):1178-1191.
PMID: 35798240
PMC: 9529910.
DOI: 10.1016/j.jtho.2022.06.011.
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.
Nguyen E, Taniguchi H, Chan J, Zhan Y, Chen X, Qiu J
J Thorac Oncol. 2022; 17(8):1014-1031.
PMID: 35691495
PMC: 9357096.
DOI: 10.1016/j.jtho.2022.05.014.
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer.
Wang W, Cho U, Yoo A, Jung C, Kim B, Kim H
Front Oncol. 2022; 12:852260.
PMID: 35646632
PMC: 9134752.
DOI: 10.3389/fonc.2022.852260.
The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery.
Bae J, Choi Y, Cho G, Jang S
Cancers (Basel). 2022; 14(9).
PMID: 35565273
PMC: 9105149.
DOI: 10.3390/cancers14092144.
Air-Liquid Interface Culture Model to Study Lung Cancer-Associated Cellular and Molecular Changes.
Agraval H, Sharma J, Dholia N, Yadav U
Methods Mol Biol. 2022; 2413:133-144.
PMID: 35044661
DOI: 10.1007/978-1-0716-1896-7_14.